Haya Therapeutics SA seeks a leader to own the global CMC strategy for therapeutic oligonucleotides, driving process development, technology transfers, and cGMP campaigns across the clinical pipeline.
You will partner with QA, Regulatory Affairs, and Clinical Operations to ensure material readiness, oversee CDMOs, and optimize synthesis, purification, and analytical method development.
A PhD and deep regulatory experience are required, with strong leadership in cross-functional, global filings.
#J-18808-LjbffrGlobal CMC Director: Therapeutic Oligonucleotides in san diego at Unknown Company
This position is listed as full time and onsite.